sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Mea Respiratory Tract Infection Treatment Market Scope And Analysis

  • Report Code : TIPRE00038996
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 201
Buy Now

Análisis del alcance del informe de mercado sobre el tratamiento de infecciones respiratorias de MEA y oportunidades para 2024-2031

Buy Now

MEA Respiratory Tract Infection Treatment Market Report MEA Respiratory Tract Infection Treatment Market Size and Share MEA Respiratory Tract Infection Treatment Market Scope and Analysis

MEA Respiratory Tract Infection Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ 2,092.80 Million
Market Size by 2031 US$ 2,975.09 Million
Global CAGR (2023 - 2031) 4.50%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Medicamentos
  • antibióticos
  • AINE
  • supresores de la tos
  • descongestionantes nasales
By Indicación de enfermedad
  • infección del tracto respiratorio superior e infección del tracto respiratorio inferior
By Vía de administración
  • oral y parenteral
By Grupo de edad
  • pediátrico y adulto
Regions and Countries Covered Oriente Medio y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • resto de Oriente Medio y África
Market leaders and key company profiles
  • Abbott Laboratories
  • AstraZeneca plc
  • Alembic Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • F. Hoffmann-La Roche AG
  • Sanofi S.A.